Huadong Medicine (Xi'an)Bodyguard Pharmaceutical Co.,Ltd.

Huadong Medicine(Xi 'an) Bodyguard Pharmaceutical Co., LTD., founded in September 1998, is a wholly-owned subsidiary of Hangzhou Zhongmei Huadong Pharmaceutical Co., LTD. Its registered capital is 80 million RMB and total assets is 160 million RMB. It covers an area of more than 125 mu with workshop of more than 10,000 square meters. The company owns 44 approval certificates, including 38 for preparations, 6 for APIs. Its products involve anti-infective drugs, cardiovascular drugs, digestive system drugs, antipyretic analgesics, psychiatric drugs and other types. The main preparations are Ornidazole Tablets, Ornidazole Suppository (Xiaoran), Omeprazole Enteric-soluble Capsules, Domperidone Tablets, Cefetamet Pivoxil Hydrochloride Tablets (Boshuli), Acetohydroxamic acid capsules (Junshitong), Glycyrrhizal Tablets (Xiyueweikang), H Dihydroxyaluminium Aminoacetate Tablets (Gandanan), Migrinin Tablets, Aspirin Enteric-coated Tablets, etc. The main API are indobufen, ornidazole, chlorhexidine acetate, chlorhexidine hydrochloride, silkworm chrysalis powder, etc. Bodyguard has nearly 300 employees, including more than 150 professional and technical personnel. The company establishes new product research and development center and has strong ability in development and application of new product, new technology, and new process. The company obtained the High-tech Enterprise Certificate in 2003 and 2020 respectively. Bodyguard has 22 core patents and in May 2020, obtained supplementary application approval certificate for consistency evaluation of Domperidone tablets and in the same year, Domperidone Tablets was included in the third batch of national drug centralized purchasing. The bidding area includes Beijing, Anhui, Fujian, Hebei, Henan, Jiangxi Province, Qinghai Province, Shandong, Shaanxi, Inner Mongolia Autonomous Region, Xinjiang Uygur Autonomous Region. The company has a perfect marketing system and marketing network covering more than 20 provinces and